Audentes plans gene therapy facility in NC

By The Science Advisory Board staff writers

February 19, 2020 -- Audentes Therapeutics has announced that it plans to invest $109 million to build a new 135,00-sq-ft gene therapy manufacturing facility in Sanford, NC, that is expected to be operational by 2021.

The fundraising phase of the project will take approximately 18 months and the remaining investment will take place over two additional planned expansion phases.

Architectural rendering of Audentes Therapeutics new gene therapy manufacturing facility planned in Sanford, NC.
Architectural rendering of Audentes Therapeutics new gene therapy manufacturing facility planned in Sanford, NC. Image courtesy of Audentes Therapeutics.

Audentes, a subsidiary of pharmaceutical developer Astellas Pharma, focuses on developing adeno associated virus (AAV)-based genetic medicines. Its extensive gene therapy portfolio targets rare neuromuscular diseases. The company uses its AAV gene therapy platform and manufacturing expertise in three areas: gene replacement, vectorized exon skipping, and vectorized RNA knockdown.

The North Carolina Department of Commerce, along with other partners, led the state's support for the company's decision to build. The facility will create over 200 new jobs in Lee County in North Carolina.

Merck to build new biotech R&D center in Switzerland
Merck announced on January 27 an investment of 250 million euros ($275 million) to build a new biotech R&D center in Corsier-sur-Vevey, Switzerland.
Krystal expands commercial gene therapy production
Krystal Biotech on January 24 announced the beginning of construction on its second commercial gene therapy facility in Findlay Township in Pennsylvania....
Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint...

Copyright © 2020 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter